A team of researchers led by Katherine L. Nathanson, MD, Basser Director of Genetics, Deputy Director of the Abramson Cancer Center, and the Pearl Basser Professor for BRCA-Related Research, was recently awarded $5.4 million over five years from the National Institutes of Health to continue the long-standing genomics work of the TEsticular CAncer Consortium (TECAC).

The Basser Center's Kara Maxwell, MD, PhD, led a study exploring the risk of developing a second primary cancer in BRCA1/2 mutation carriers.

Basser researcher Kara N. Maxwell, MD, PhD, is the lead author of a recent study about a newly-described genetic mutation in the TP53 gene, which can increase the risk of developing multiple types of cancer. Basser genetic counselor Jacquelyn Powers, MS, LCGC, was a co-first author on the study.

Basser researcher Kara N. Maxwell, MD, PhD, is the lead author of a recent study about a newly-described genetic mutation in the TP53 gene, which can increase the risk of developing multiple types of cancer. Basser genetic counselor Jacquelyn Powers, MS, LCGC, was a co-first author on the study.

Cancer Network interviewed the Basser Center's Angela R. Bradbury, MD, about Penn’s efforts to continue genetic counseling during the COVID-19 pandemic.

Basser researcher and Penn Medicine oncologist Kim Reiss Binder, MD, shares the difficulty of treating cancer patients during the pandemic. "As our patients have taught us, we must continue to hope for a brighter tomorrow."

Harvey Parker generously shares the story of his pancreatic cancer treatment and his participation in a Basser Center and Penn Medicine clinical trial run by Dr. Kim Reiss Binder.

Using innovative techniques, a new Penn Medicine study helps clear up mystery about why PARP-inhibiting compounds vary so much in their clinical effectiveness.

Using innovative techniques, a new Penn Medicine study helps clear up mystery about why PARP-inhibiting compounds vary so much in their clinical effectiveness.

How do you make major life decisions knowing you are likely to develop cancer? Allison Werner-Lin looks at these questions, studying the intersection of genetics and family life.